{"id":"https://openalex.org/W3017340431","doi":"https://doi.org/10.1136/ejhpharm-2020-eahpconf.380","title":"5PSQ-063 Serious cellulitis in a patient with atopic dermatitis treated with baricitinib: a case report","display_name":"5PSQ-063 Serious cellulitis in a patient with atopic dermatitis treated with baricitinib: a case report","publication_year":2020,"publication_date":"2020-03-01","ids":{"openalex":"https://openalex.org/W3017340431","doi":"https://doi.org/10.1136/ejhpharm-2020-eahpconf.380","mag":"3017340431"},"language":"en","primary_location":{"id":"doi:10.1136/ejhpharm-2020-eahpconf.380","doi":"https://doi.org/10.1136/ejhpharm-2020-eahpconf.380","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ejhpharm-2020-eahpconf.380","pdf_url":"https://ejhp.bmj.com/content/ejhpharm/27/Suppl_1/A178.2.full.pdf","source":{"id":"https://openalex.org/S3012707348","display_name":"European Journal of Hospital Pharmacy","issn_l":"2047-9956","issn":["2047-9956","2047-9964"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Section 5: Patient Safety and Quality assurance","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ejhp.bmj.com/content/ejhpharm/27/Suppl_1/A178.2.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024301889","display_name":"M Guti\u00e9rrez Lorenzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110917","display_name":"Hospital de Poniente","ror":"https://ror.org/017a18y80","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210110917"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M Guti\u00e9rrez Lorenzo","raw_affiliation_strings":["Hospital De Poniente, Farmacia, Almer\u00eda, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital De Poniente, Farmacia, Almer\u00eda, Spain","institution_ids":["https://openalex.org/I4210110917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028793943","display_name":"M Herrera Exp\u00f3sito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110917","display_name":"Hospital de Poniente","ror":"https://ror.org/017a18y80","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210110917"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M Herrera Exp\u00f3sito","raw_affiliation_strings":["Hospital De Poniente, Farmacia, Almer\u00eda, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital De Poniente, Farmacia, Almer\u00eda, Spain","institution_ids":["https://openalex.org/I4210110917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020530702","display_name":"A Martos Rosa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110917","display_name":"Hospital de Poniente","ror":"https://ror.org/017a18y80","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210110917"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A Martos Rosa","raw_affiliation_strings":["Hospital De Poniente, Farmacia, Almer\u00eda, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital De Poniente, Farmacia, Almer\u00eda, Spain","institution_ids":["https://openalex.org/I4210110917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078735965","display_name":"CM Pinto Nieto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110917","display_name":"Hospital de Poniente","ror":"https://ror.org/017a18y80","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210110917"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"CM Pinto Nieto","raw_affiliation_strings":["Hospital De Poniente, Farmacia, Almer\u00eda, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital De Poniente, Farmacia, Almer\u00eda, Spain","institution_ids":["https://openalex.org/I4210110917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056836634","display_name":"MA Castro Vida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110917","display_name":"Hospital de Poniente","ror":"https://ror.org/017a18y80","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210110917"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M Castro Vida","raw_affiliation_strings":["Hospital De Poniente, Farmacia, Almer\u00eda, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital De Poniente, Farmacia, Almer\u00eda, Spain","institution_ids":["https://openalex.org/I4210110917"]}]},{"author_position":"last","author":{"id":null,"display_name":"\u00c1ngeles","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u00c1ngeles","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1633,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.88607595,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":null,"issue":null,"first_page":"A178.2","last_page":"A179"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.8223000168800354,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.8223000168800354,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11153","display_name":"Streptococcal Infections and Treatments","score":0.10660000145435333,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0215000007301569,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/baricitinib","display_name":"baricitinib","score":0.984000027179718},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cellulitis","display_name":"cellulitis","score":0.8379999995231628},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.7409999966621399},{"id":"https://openalex.org/keywords/streptococcus-pyogenes","display_name":"Streptococcus pyogenes","score":0.7879999876022339},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7919999957084656},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7139999866485596},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.7459999918937683},{"id":"https://openalex.org/keywords/lymphopenia","display_name":"lymphopenia","score":0.6029999852180481},{"id":"https://openalex.org/keywords/wound-debridement","display_name":"wound debridement","score":0.7200000286102295},{"id":"https://openalex.org/keywords/penicillin","display_name":"penicillin","score":0.5320000052452087},{"id":"https://openalex.org/keywords/clindamycin","display_name":"clindamycin","score":0.996999979019165},{"id":"https://openalex.org/keywords/meropenem","display_name":"meropenem","score":0.6919999718666077},{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":0.9279999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9538544416427612},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.6184501051902771},{"id":"https://openalex.org/C2777238321","wikidata":"https://www.wikidata.org/wiki/Q876887","display_name":"Cellulitis","level":2,"score":0.5799099802970886},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5558345913887024},{"id":"https://openalex.org/C2777458120","wikidata":"https://www.wikidata.org/wiki/Q422273","display_name":"Clindamycin","level":3,"score":0.5075546503067017},{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.46335864067077637},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.4325621426105499},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.38996368646621704},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2613210082054138},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.24365440011024475},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.1907804310321808},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/ejhpharm-2020-eahpconf.380","doi":"https://doi.org/10.1136/ejhpharm-2020-eahpconf.380","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ejhpharm-2020-eahpconf.380","pdf_url":"https://ejhp.bmj.com/content/ejhpharm/27/Suppl_1/A178.2.full.pdf","source":{"id":"https://openalex.org/S3012707348","display_name":"European Journal of Hospital Pharmacy","issn_l":"2047-9956","issn":["2047-9956","2047-9964"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Section 5: Patient Safety and Quality assurance","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/ejhpharm-2020-eahpconf.380","doi":"https://doi.org/10.1136/ejhpharm-2020-eahpconf.380","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ejhpharm-2020-eahpconf.380","pdf_url":"https://ejhp.bmj.com/content/ejhpharm/27/Suppl_1/A178.2.full.pdf","source":{"id":"https://openalex.org/S3012707348","display_name":"European Journal of Hospital Pharmacy","issn_l":"2047-9956","issn":["2047-9956","2047-9964"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Section 5: Patient Safety and Quality assurance","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320323834","display_name":"Universidad de Granada","ror":"https://ror.org/04njjy449"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3017340431.pdf","grobid_xml":"https://content.openalex.org/works/W3017340431.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387729024","https://openalex.org/W3193860292","https://openalex.org/W6903785231","https://openalex.org/W3087665791","https://openalex.org/W4309472353","https://openalex.org/W3173232843","https://openalex.org/W3195008458","https://openalex.org/W4317681683","https://openalex.org/W4210273628","https://openalex.org/W4323653286"],"abstract_inverted_index":{"Background":[0],"and":[1,54,57,77,91,108,128,152,179,193,201,213,230,236,247,274,306,317,325],"importance":[2],"Baricitinib":[3,190],"is":[4,13],"an":[5,29],"orally":[6],"available":[7],"inhibitor":[8],"of":[9,64,98,135,220,225,261,280,346],"Janus":[10],"kinases":[11],"that":[12,42],"used":[14],"to":[15,18,27,133,168,255,299,313],"treat":[16],"moderate":[17],"severe":[19,62,114,173],"rheumatoid":[20],"arthritis.":[21],"In":[22,203],"the":[23,43,155,164,169,185,205,245,265,314],"literature,":[24],"baricitinib":[25,38,142,293,319,324],"seems":[26],"be":[28,330],"alternative":[30],"in":[31,48,66,117,158,184,264,288,338],"dermatologic":[32],"diseases":[33],"as":[34],"off-label":[35],"treatment.":[36,281],"The":[37,86],"technical":[39],"sheet":[40],"describes":[41],"most":[44],"frequent":[45],"serious":[46],"infections":[47,328],"clinical":[49,84,92],"trials":[50],"were":[51,94,124,215],"herpes":[52],"zoster":[53],"cellulitis.":[55],"Aim":[56],"objectives":[58],"To":[59],"describe":[60],"a":[61,67,81,285],"case":[63],"cellulitis":[65,175],"patient":[68,165,206],"with":[69,74,106,113,141,176,199,234,244],"atopic":[70,115,122],"dermatitis":[71,116,123],"previously":[72],"treated":[73],"baricitinib.":[75],"Material":[76],"methods":[78],"This":[79,308],"was":[80,111,143,166,188,191,197,238,250,269,294,311],"descriptive,":[82],"retrospective":[83],"case.":[85],"data":[87],"(diagnostic":[88],"tests,":[89],"therapy":[90,196,233],"course)":[93],"obtained":[95],"by":[96,148,154,292,323],"review":[97],"electronic":[99],"medical":[100,156],"records.":[101],"Results":[102],"A":[103],"63-year-old":[104],"man":[105],"hypertension":[107],"diabetes":[109],"mellitus":[110],"diagnosed":[112],"2017.":[118],"Previous":[119],"treatments":[120],"for":[121,172,210,259,303],"corticosteroids,":[125],"ciclosporin,":[126],"methotrexate":[127],"apremilast,":[129],"all":[130],"suspended":[131,192,270],"due":[132],"lack":[134],"efficacy":[136],"or":[137],"adverse":[138,309],"reactions.":[139],"Treatment":[140],"initiated":[144],"after":[145,271,277],"being":[146],"processed":[147],"our":[149],"hospital":[150],"pharmacy":[151],"authorised":[153],"director,":[157],"May":[159],"2019.":[160],"Four":[161],"months":[162],"later,":[163,284],"admitted":[167],"traumatology":[170],"service":[171],"extensive":[174],"associated":[177],"phascitis":[178],"pharmacological":[180],"immunosuppression":[181],"(lymphocyte":[182],"count":[183,249],"first":[186],"determination":[187],"0.51\u00d710\u00d73/\u00b5L).":[189],"empirical":[194,221],"antibiotic":[195,232],"started":[198],"meropenem":[200],"linezolid.":[202],"addition,":[204],"underwent":[207],"surgery":[208,258],"twice":[209],"wound":[211],"debridement":[212],"samples":[214],"taken.":[216],"After":[217],"6":[218],"days":[219,273,279],"treatment,":[222],"microbiological":[223],"culture":[224],"exudate":[226],"revealed":[227],"Streptococcus":[228],"pyogenes,":[229],"directed":[231],"penicillin":[235,275],"clindamycin":[237],"given.":[239],"Skin":[240],"lesions":[241],"improved":[242],"progressively":[243],"treatment":[246,337],"lymphocyte":[248],"1.12\u00d710\u00d73/\u00b5L.":[251],"However,":[252],"he":[253,297],"had":[254],"undergo":[256],"plastic":[257],"loss":[260],"granulated":[262],"substance":[263],"affected":[266],"tissue.":[267],"Clindamycin":[268],"7":[272],"G":[276],"14":[278],"One":[282],"month":[283],"significant":[286],"improvement":[287],"cutaneous":[289],"injuries":[290],"caused":[291,318,322],"observed,":[295],"although":[296],"continued":[298],"need":[300],"daily":[301],"cures":[302],"sequels.":[304],"Conclusion":[305],"relevance":[307],"reaction":[310],"reported":[312],"pharmacovigilance":[315],"centre":[316],"discontinuation.":[320],"Immunosuppression":[321],"probable":[326],"subsequent":[327],"should":[329],"taken":[331],"into":[332],"account":[333],"when":[334],"starting":[335],"this":[336],"susceptible":[339],"patients.":[340],"References":[341],"and/or":[342],"acknowledgements":[343],"No":[344],"conflict":[345],"interest.":[347]},"counts_by_year":[{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2020-04-24T00:00:00"}
